Global Cardiology Defibrillators Market (Sales, Revenue, Price, Gross Profit and Competitors Analysis of Major Market) from 2016-2027
- Published Date: 2021-04-23
- Report ID: 104736
- Pages: 116
-
Format:
Summary
As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%.
Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the 'epicenter' of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States.
In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter.
Compared with the United States, Europe's economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany's GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970.
Thanks to the effective control and policy support of the new epidemic, China's economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales. Prudent Markets published a report for global Cardiology Defibrillators market in this environment.
In terms of revenue, this research report indicated that the global Cardiology Defibrillators market was valued at USD XXX million in 2020, and it is expected to reach a value of USD XXX million by 2027, at a CAGR of XX % over the forecast period 2021-2027. Correspondingly, the forecast analysis of Cardiology Defibrillators industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments.
The Biotronik aims at producing XX K Units Cardiology Defibrillators in 2020, with XX % production to take place in global market, Boston Scientific Corporation accounts for a volume share of XX %.
Regional Segmentation (Value; Revenue, USD Million, 2026-2027) of Cardiology Defibrillators Market by Prudent Markets Include
China
EU
USA
Japan
India
Southeast Asia
South America
Competitive Analysis; Who are the Major Players in Cardiology Defibrillators Market
Biotronik
Boston Scientific Corporation
Cardiac Science Corporation
Heartsine Technologies
Medtronic
Nihon Kohden
Philips Healthcare; Heartstream Division
Physio-Control
ST.Jude Medical
Sorin GroupZoll Medical
Cardiac Science
Laerdal Medical Corporation
Medical Research Laboratories
Medtronic Physio-Control Corporation
Defibtech
...
Major Type of Cardiology Defibrillators Covered in Prudent Markets report:
Implantable Cardioverter Defibrillator (ICDs)
External Defibrillator
Wearable Cardioverter Defibrillator (WCDs)
Application Segments Covered in Prudent Markets Market
Hospitals
Institutes
Others
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents
Global Cardiology Defibrillators Market Analysis 2021, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate
1 Market Scope
1.1 Product Details and Introduction
1.1.1 Implantable Cardioverter Defibrillator (ICDs) -Product Introduction and Major Manufacturers
1.1.2 External Defibrillator -Product Introduction and Major Manufacturers
1.1.3 Wearable Cardioverter Defibrillator (WCDs) -Product Introduction and Major Manufacturers
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Global Cardiology Defibrillators Market Assessment, by Segmentation
2.1 Type Breakdown Estimates & Forecast, Sales Volume (2026-2027)
2.2 Type Breakdown Estimates & Forecast, Sales Value (2026-2027)
2.3 Application Breakdown Estimates & Forecast, by Application (2026-2027)
3 Regional Market Analysis
3.1 China Cardiology Defibrillators Market
3.1.1 Top Companies leading Cardiology Defibrillators Development in China (2016-2021)
3.1.2 Sales Value of Major Company in China Market (2016-2021)
3.1.3 China Cardiology Defibrillators Price (USD/Unit), by Type (2019-2020)
3.1.4 Sales in China Market, by Type (2026-2027)
3.2 EU Cardiology Defibrillators Market
3.2.1 Top Companies leading Cardiology Defibrillators Development in EU (2016-2021)
3.2.2 Sales Value of Major Company in EU Market (2016-2021)
3.2.3 EU Cardiology Defibrillators Price (USD/Unit), by Type (2019-2020)
3.2.4 Sales in EU Market, by Type (2026-2027)
3.3 USA Cardiology Defibrillators Market
3.3.1 Top Companies leading Cardiology Defibrillators Development in USA (2016-2021)
3.3.2 Sales Value of Major Company in USA Market (2016-2021)
3.3.3 USA Cardiology Defibrillators Price (USD/Unit), by Type (2019-2020)
3.3.4 Sales in USA Market, by Type (2026-2027)
3.4 Japan Cardiology Defibrillators Market
3.4.1 Top Companies leading Cardiology Defibrillators Development in Japan (2016-2021)
3.4.2 Sales Value of Major Company in Japan Market (2016-2021)
3.4.3 Japan Cardiology Defibrillators Price (USD/Unit), by Type (2019-2020)
3.4.4 Sales in Japan Market, by Type (2026-2027)
3.5 India Cardiology Defibrillators Market
3.5.1 Top Companies leading Cardiology Defibrillators Development in India (2016-2021)
3.5.2 Sales Value of Major Company in India Market (2016-2021)
3.5.3 India Cardiology Defibrillators Price (USD/Unit), by Type (2019-2020)
3.5.4 Sales in India Market, by Type (2026-2027)
3.6 Southeast Asia Cardiology Defibrillators Market
3.6.1 Top Companies leading Cardiology Defibrillators Development in Southeast Asia (2016-2021)
3.6.2 Sales Value of Major Company in Southeast Asia Market (2016-2021)
3.6.3 Southeast Asia Cardiology Defibrillators Price (USD/Unit), by Type (2019-2020)
3.6.4 Sales in Southeast Asia Market, by Type (2026-2027)
3.7 South America Cardiology Defibrillators Market
3.7.1 Top Companies leading Cardiology Defibrillators Development in South America (2016-2021)
3.7.2 Sales Value of Major Company in South America Market (2016-2021)
3.7.3 South America Cardiology Defibrillators Price (USD/Unit), by Type (2019-2020)
3.7.4 Sales in South America Market, by Type (2026-2027)
4 Value Chain (Impact of COVID-19)
4.1 Cardiology Defibrillators Value Chain Analysis
4.1.1 Upstream
4.1.2 Downstream
4.2 COVID-19 Impact on Cardiology Defibrillators Industry
4.2.1 Industrial Policy Issued Under the Epidemic Situation
4.3 Cost-Under the Epidemic Situation
4.3.1 Cost of Raw Material
4.4 Channel Analysis
4.4.1 Distribution Channel-Under the Epidemic Situation
4.4.2 Distributors
5 Regional Market Forecast (2021-2027)
5.1 Global Cardiology Defibrillators Sales and Growth Rate (2021-2027)
5.2 Global Cardiology Defibrillators Sales Value and Growth Rate (2021-2027)
6 Cardiology Defibrillators Competitive Analysis
6.1 Biotronik
6.1.1 Biotronik Company Profiles
6.1.2 Biotronik Product Introduction
6.1.3 Biotronik Cardiology Defibrillators Production, Revenue (2016-2021)
6.1.4 SWOT Analysis
6.2 Boston Scientific Corporation
6.2.1 Boston Scientific Corporation Company Profiles
6.2.2 Boston Scientific Corporation Product Introduction
6.2.3 Boston Scientific Corporation Cardiology Defibrillators Production, Revenue (2016-2021)
6.2.4 SWOT Analysis
6.3 Cardiac Science Corporation
6.3.1 Cardiac Science Corporation Company Profiles
6.3.2 Cardiac Science Corporation Product Introduction
6.3.3 Cardiac Science Corporation Cardiology Defibrillators Production, Revenue (2016-2021)
6.3.4 SWOT Analysis
6.4 Heartsine Technologies
6.4.1 Heartsine Technologies Company Profiles
6.4.2 Heartsine Technologies Product Introduction
6.4.3 Heartsine Technologies Cardiology Defibrillators Production, Revenue (2016-2021)
6.4.4 SWOT Analysis
6.5 Medtronic
6.5.1 Medtronic Company Profiles
6.5.2 Medtronic Product Introduction
6.5.3 Medtronic Cardiology Defibrillators Production, Revenue (2016-2021)
6.5.4 SWOT Analysis
6.6 Nihon Kohden
6.6.1 Nihon Kohden Company Profiles
6.6.2 Nihon Kohden Product Introduction
6.6.3 Nihon Kohden Cardiology Defibrillators Production, Revenue (2016-2021)
6.6.4 SWOT Analysis
6.7 Philips Healthcare; Heartstream Division
6.7.1 Philips Healthcare; Heartstream Division Company Profiles
6.7.2 Philips Healthcare; Heartstream Division Product Introduction
6.7.3 Philips Healthcare; Heartstream Division Cardiology Defibrillators Production, Revenue (2016-2021)
6.7.4 SWOT Analysis
6.8 Physio-Control
6.8.1 Physio-Control Company Profiles
6.8.2 Physio-Control Product Introduction
6.8.3 Physio-Control Cardiology Defibrillators Production, Revenue (2016-2021)
6.8.4 SWOT Analysis
6.9 ST.Jude Medical
6.9.1 ST.Jude Medical Company Profiles
6.9.2 ST.Jude Medical Product Introduction
6.9.3 ST.Jude Medical Cardiology Defibrillators Production, Revenue (2016-2021)
6.9.4 SWOT Analysis
6.10 Sorin GroupZoll Medical
6.10.1 Sorin GroupZoll Medical Company Profiles
6.10.2 Sorin GroupZoll Medical Product Introduction
6.10.3 Sorin GroupZoll Medical Cardiology Defibrillators Production, Revenue (2016-2021)
6.10.4 SWOT Analysis
6.11 Cardiac Science
6.12 Laerdal Medical Corporation
6.13 Medical Research Laboratories
6.14 Medtronic Physio-Control Corporation
6.15 Defibtech
7 Conclusion
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
